The Avastin in Glioblastoma trial has shown that patients newly diagnosed with glioblastoma multiforme (GBM) treated with bevacizumab plus radiotherapy (RT) and temozolomide versus RT and temozolomide alone showed improvement in PFS, possibly leading to a new indication for first-line use of bevacizumab in GBM.

READ FULL ARTICLE Curated publisher From Ascopubs